[Summary] Absol, a high-sensitivity in vitro immunodiagnostic device developed by Absol (CEO Cho Han Sang), and an animal diagnostic device 'ABSOL VET' are attracting attention in the Middle East.

https://www.dailymedi.com/news/news_view.php?wr_id=879765 

Excerpt from Dailymedi